Search Results - "Federico Oppenheimer"

Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment by Lefaucheur, Carmen, Viglietti, Denis, Hidalgo, Luis G, Ratner, Lloyd E, Bagnasco, Serena M, Batal, Ibrahim, Aubert, Olivier, Orandi, Babak J, Oppenheimer, Federico, Bestard, Oriol, Rigotti, Paolo, Reisaeter, Anna V, Kamar, Nassim, Lebranchu, Yvon, Duong Van Huyen, Jean-Paul, Bruneval, Patrick, Glotz, Denis, Legendre, Christophe, Empana, Jean-Philippe, Jouven, Xavier, Segev, Dorry L, Montgomery, Robert A, Zeevi, Adriana, Halloran, Philip F, Loupy, Alexandre

“…Complement-activating anti-HLA donor-specific antibodies (DSAs) are associated with impaired kidney transplant outcome; however, whether these antibodies…”
Get full text

Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study by Aubert, Olivier, Divard, Gillian, Pascual, Julio, Oppenheimer, Federico, Sommerer, Claudia, Citterio, Franco, Tedesco, Helio, Chadban, Steve, Henry, Mitchell, Vincenti, Flavio, Srinivas, Titte, Watarai, Yoshihiko, Legendre, Christophe, Bernhardt, Peter, Loupy, Alexandre

“…ObjectivesDevelopment of pharmaceutical agents in transplantation is currently limited by long waits for hard endpoints. We applied a validated integrative…”
Get full text

Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy by Quintana, Luis F, Blasco, Miquel, Seras, Miguel, Pérez, Nuria S, López-Hoyos, Marcos, Villarroel, Patricia, Rodrigo, Emilio, Viñas, Odette, Ercilla, Guadalupe, Diekmann, Fritz, Gómez-Roman, José J, Fernandez-Fresnedo, Gema, Oppenheimer, Federico, Arias, Manuel, Campistol, Josep M

“…Secretory phospholipase A2 receptor (PLA2R) is the target antigen of the auto-antibodies produced in most (∼ 70%) patients with primary membranous nephropathy…”
Get full text

mTOR inhibitor–associated proteinuria in kidney transplant recipients by Diekmann, Fritz, Andrés, Amado, Oppenheimer, Federico

“…Abstract The use of mammalian target of rapamycin inhibitor (mTOR-I) after kidney transplantation has been associated with a higher incidence of proteinuria…”
Get full text

Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection by Piñeiro, Gastón J, De Sousa-Amorim, Erika, Solé, Manel, Ríos, José, Lozano, Miguel, Cofán, Frederic, Ventura-Aguiar, Pedro, Cucchiari, David, Revuelta, Ignacio, Cid, Joan, Palou, Eduard, Campistol, Josep M, Oppenheimer, Federico, Rovira, Jordi, Diekmann, Fritz

“…Chronic active antibody-mediated rejection (c-aABMR) is an important cause of allograft failure and graft loss in long-term kidney transplants. To determine…”
Get full text

Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipients by Colom, Helena, Lloberas, Núria, Andreu, Franc, Caldés, Ana, Torras, Joan, Oppenheimer, Federico, Sanchez-Plumed, Jaime, Gentil, Miguel A, Kuypers, Dirk R, Brunet, Mercè, Ekberg, Henrik, Grinyó, Josep M

“…Several factors contribute to mycophenolic acid (MPA) between-patient variability. Here we characterize the metabolic pathways of MPA and quantify the effect…”
Get more information

Efficacy of Eculizumab in the Treatment of Recurrent Atypical Hemolytic-Uremic Syndrome After Renal Transplantation by FERNANDEZ-DE LARREA, Carlos, COFAN, Frederic, OPPENHEIMER, Federico, CAMPISTOL, Josep Maria, ESCOLAR, Gines, LOZANO, Miguel

Get full text

Tofacitinib halts progression of graft dysfunction in a rat model of mixed cellular and humoral rejection by Rovira, Jordi, Ramírez-Bajo, María J, Banon-Maneus, Elisenda, Lazo-Rodríguez, Marta, Moya-Rull, Daniel, Hierro-Garcia, Natalia, Tubita, Valeria, Piñeiro, Gastón J, Revuelta, Ignacio, Ventura-Aguiar, Pedro, Cucchiari, David, Oppenheimer, Federico, Brunet, Mercè, Campistol, Josep M, Diekmann, Fritz

“…BACKGROUNDThe progression from acute to chronic antibody-mediated rejection in kidney transplant recipients is usually not prevented by current therapeutic…”
Get full text

Psychosocial risk factors for impaired health-related quality of life in living kidney donors: results from the ELIPSY prospective study by Menjivar, Ana, Torres, Xavier, Manyalich, Marti, Fehrman-Ekholm, Ingela, Papachristou, Christina, de Sousa-Amorim, Erika, Paredes, David, Hiesse, Christian, Yucetin, Levent, Oppenheimer, Federico, Kondi, Entela, Peri, Josep Maria, Kvarnström, Niclas, Ballesté, Chloë, Dias, Leonidio, Frade, Inês C., Lopes, Alice, Diekmann, Fritz, Revuelta, Ignacio

“…Living kidney donors’ follow-up is usually focused on the assessment of the surgical and medical outcomes. Whilst the psychosocial follow-up is advocated in…”
Get full text

Assessment of donor satisfaction as an essential part of living donor kidney transplantation: an eleven-year retrospective study by Menjivar, Ana, Torres, Xavier, Paredes, David, Avinyo, Nuria, Peri, Josep Maria, De Sousa-Amorim, Erika, Oppenheimer, Federico, Manyalich, Marti, Diekmann, Fritz, Revuelta, Ignacio

“…Living kidney donors seem highly satisfied with donation. However, previous studies measure satisfaction by a single-item or by simply questioning donors'…”
Get more information

Perioperative prophylaxis with ertapenem reduced infections caused by extended-spectrum betalactamase-producting Enterobacteriaceae after kidney transplantation by Sanclemente, Gemma, Bodro, Marta, Cervera, Carlos, Linares, Laura, Cofán, Frederic, Marco, Francesc, Bosch, Jordi, Oppenheimer, Federico, Dieckmann, Fritz, Moreno, Asunción

“…In recent years we have witnessed an increase in infections due to multidrug-resistant organisms in kidney transplant recipients (KTR). In our setting, we have…”
Get full text

Predictors of Success in Conversion from Calcineurin Inhibitor to Sirolimus in Chronic Allograft Dysfunction by Diekmann, Fritz, Budde, Klemens, Oppenheimer, Federico, Fritsche, Lutz, Neumayer, Hans H., Campistol, Josep M.

“…Chronic allograft dysfunction (CAD) is a major cause of graft loss in long‐term kidney transplant recipients. To identify predictors of successful conversion…”
Get full text

Antifungal prophylaxis with nebulized amphotericin-B in solid-organ transplant recipients with severe COVID-19: a retrospective observational study by Rombauts, Alexander, Bodro, Marta, Daniel Gumucio, Victor, Carbonell, Irene, Favà, Àlex, Lladó, Laura, González-Costello, José, Oppenheimer, Federico, Castel-Lavilla, María Ángeles, Len, Oscar, Marquez-Algaba, Ester, Nuvials-Casals, Xavier, Martínez González, Daniel, Lacasa, Judith Sacanell, Carratalà, Jordi, Sabé, Nuría

“…COVID-19-associated pulmonary aspergillosis (CAPA) has emerged as a frequent complication in the intensive care unit (ICU). However, little is known about this…”
Get full text

Impact of Mesenchymal Stromal Cells and Their Extracellular Vesicles in a Rat Model of Kidney Rejection by Ramirez-Bajo, Maria Jose, Rovira, Jordi, Lazo-Rodriguez, Marta, Banon-Maneus, Elisenda, Tubita, Valeria, Moya-Rull, Daniel, Hierro-Garcia, Natalia, Ventura-Aguiar, Pedro, Oppenheimer, Federico, Campistol, Josep M, Diekmann, Fritz

“…Mesenchymal stromal cells (MSCs) from different sources possess great therapeutic potential due to their immunomodulatory properties associated with allograft…”
Get full text

The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy by Grinyó, Josep M., Ekberg, Henrik, Mamelok, Richard D., Oppenheimer, Federico, Sánchez-Plumed, Jaime, Gentil, Miguel Angel, Hernandez, Domingo, Kuypers, Dirk R., Brunet, Mercé

“…Background. Exposure to mycophenolic acid (MPA), the primary active metabolite of mycophenolate mofetil (MMF), is correlated with therapeutic efficacy of MMF…”
Get full text

Long-term outcome of antineutrophil cytoplasmic antibody-associated small vessel vasculitis after renal transplantation by Marco, Helena, Mirapeix, Eduard, Arcos, Emma, Comas, Jordi, Ara, Jordi, Gil-Vernet, Salvador, Puig, Josep, Vinyas, Odette, Perello, Manel, Oppenheimer, Federico, Poveda, Rafael, Ibernón, Meritxell, Díaz, Montserrat, Ballarin, Jose

“…The survival after renal transplantation of patients with antineutrophil cytoplasmic antibody (ANCA)‐associated to systemic vasculitis is as good as in other…”
Get full text

Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities by Pascual, Julio, Diekmann, Fritz, Fernández-Rivera, Constantino, Gómez-Marqués, Gonzalo, Gutiérrez-Dalmau, Alex, Pérez-Sáez, María José, Sancho-Calabuig, Asunción, Oppenheimer, Federico

“…The immunosuppressive combination most commonly used in de novo kidney transplantation comprises a calcineurin inhibitor (CI), tacrolimus, a mycophenolic acid…”
Get full text

B Cell-Derived Extracellular Vesicles Reveal Residual B Cell Activity in Kidney Graft Recipients Undergoing Pre-Transplant Desensitization by Cucchiari, David, Tubita, Valeria, Rovira, Jordi, Ramirez-Bajo, Maria J, Banon-Maneus, Elisenda, Lazo-Rodriguez, Marta, Hierro-Garcia, Natalia, Borràs, Francesc E, Ventura-Aguiar, Pedro, Piñeiro, Gastón J, Martorell, Jaume, Peri, Lluís, Musquera, Mireia, Hertig, Alexandre, Oppenheimer, Federico, Campistol, Josep M, Diekmann, Fritz, Revuelta, Ignacio

“…Living-donor kidney transplant (LDKT) recipients undergoing desensitization for Human Leukocyte Antigen (HLA)-incompatibility have a high risk of developing…”
Get full text

Influence of Persistent Inflammation in Follow-Up Biopsies After Antibody-Mediated Rejection in Kidney Transplantation by Piñeiro, Gaston J., Montagud-Marrahi, Enrique, Ríos, José, Ventura-Aguiar, Pedro, Cucchiari, David, Revuelta, Ignacio, Lozano, Miquel, Cid, Joan, Cofan, Frederic, Esforzado, Nuria, Palou, Eduard, Oppenheimer, Federico, Campistol, Josep M., Bayés-Genís, Beatriu, Rovira, Jordi, Diekmann, Fritz

“…Background: Despite recent advances in immunosuppression treatment, antibody-mediated rejection (ABMR) remains the leading cause of kidney graft loss…”
Get full text

An mTOR-inhibitor-based protocol and calcineurin inhibitor (CNI)-free treatment in kidney transplant recipients from donors after cardiac death: good renal function, but high incidence of conversion to CNI by Sánchez-Escuredo, Ana, Diekmann, Fritz, Revuelta, Ignacio, Esforzado, Nuria, Ricart, Maria Jose, Cofán, Frederic, Torregrosa, Jose-Vicente, Peri, Lluis, Ruiz, Ángel, Campistol, Josep Maria, Oppenheimer, Federico

“…Donor after cardiac death (DCD) grafts have excellent survival despite the high incidence of delayed graft function (DGF). We assessed the feasibility of a…”
Get more information